Articles related to ALOPECIA/HAIR LOSS

Eleven infants in Spain developed hypertrichosis in 2024 after secondary exposure to caregivers’ topical minoxidil, with symptoms resolving once exposure ended.

A novel oral extended-release minoxidil formulation produced significantly greater non-vellus hair counts and patient-reported coverage improvement than placebo in men with androgenetic alopecia at six months.

“Hair loss can be very debilitating. We should start thinking about more proactive strategies to mitigate risks.” — Yagiz Matthew Akiska, MD/MPH candidate, George Washington University

“Hair loss usually reverses once you stop taking an antidepressant. But you shouldn’t stop taking an antidepressant on your own. This can cause serious side effects, especially if you’ve been taking it for a while.”

Progressive follicular miniaturization driven by DHT activity transforms terminal hairs into fine vellus hairs through shortened anagen phases, creating characteristic thinning patterns that respond to early intervention.

Topical finasteride absorption through skin into bloodstream produces adverse events consistent with approved oral finasteride products, with 32 documented cases including erectile dysfunction, anxiety, and cognitive symptoms reported between 2019-2024.